Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the stock. Moleculin Biotech Stock Performance Shares of Moleculin Biotech stock opened at $0.61 on Wednesday. The business’s 50 day moving average price is $0.51 and its 200 day […]
More Stories
Head-To-Head Analysis: Bath & Body Works (BBWI) versus Its Peers
Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 publicly-traded companies in the “Retail stores, not...
Agilent Technologies (NYSE:A) Raised to Buy at StockNews.com
Agilent Technologies (NYSE:A – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy”...
StockNews.com Upgrades Workday (NASDAQ:WDAY) to Buy
Workday (NASDAQ:WDAY – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating...
Sienna Resources (CVE:SIE) Trading 16.7% Higher – Time to Buy?
Sienna Resources Inc. (CVE:SIE – Get Free Report) shares rose 16.7% on Tuesday . The company traded as high as...
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...